Skip to main content

2022 Award WinnerDianne Rausch

NIAID (National Institute of Allergy and Infectious Diseases)


Scientific/Medical Group Awards

HPTN 083 & HPTN 084 Clinical Trial Team

In recognition of exceptional conduct of the HPTN 083 & HPTN 084 clinical trials that resulted in FDA approval of Cabotegravir Long Acting (CAB LA).


Administrative Group Awards

Ending the HIV Epidemic Team

For extraordinary dedication and teamwork in supporting the Department of Health and Human Service's Ending the HIV Epidemic initiative to inform best practices through research.